Clinical Trial: Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Pentoxifylline as an Adjunct Therapy in the Treatment of Pneumonia
Study Type: INTERVENTIONAL
Official Title: Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug
Brief Summary:
Pentoxifylline is a xanthine-derived, commercially produced drug approved for the management of intermittent claudication in patients suffering from a chronic occlusive arterial disease of the limbs.Pentoxifylline has been documented to display anti-inflammatory and immunomodulatory effects, as well as some antithrombotic and antiviral effects.This drug has also been shown to reduce lung fibrosis in patients with COVID-19, as well as to prevent thromboembolic events.This work aims to assess the benefit of oral…
Read more